BioNTech SE American Depositary Share
BioNTech SE American Depositary S.../ US09075V1026 /
BNTX
|
10/11/2024 9:05:33 PM
|
Chg.
+1.96
|
Volume |
Bid9:05:44 PM |
Ask9:05:44 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
120.49USD
|
+1.65%
|
25,825
Turnover: 3.1 mill. |
113.32Bid Size: 208 |
121.61Ask Size: 278 |
-USD |
- |
- |
Fundamentals
| |
FY 2021 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
42.18 EUR |
70,200.00% |
| EPS Diluted: |
39.63 EUR |
65,950.00% |
| Revenues per Share: |
- EUR |
- |
| Book Value per Share: |
- EUR |
- |
| Cash Flow per Share: |
- EUR |
- |
| Dividend per Share: |
- EUR |
- |
| Total |
in mill. |
|
| Revenues: |
18,976.70 EUR |
3,834.63% |
| Net Income: |
10,292.50 EUR |
67,613.82% |
| Operating Cash Flow: |
889.70 EUR |
- |
| Cash and Cash Equivalents: |
1,692.70 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
2.61 |
5.07 |
| P/S Ratio: |
- |
- |
| P/BV ratio: |
- |
- |
| P/CF Ratio: |
- |
- |
| PEG: |
0.00 |
0.00 |
| Earnings Yield: |
38.30% |
19.71% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
- USD |
- USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
9.3 mill. USD |
19.19 mill. USD |
| Shares Outstanding: |
242.52 mill. |
|
Profitability
| Gross Profit Margin: |
84.66% |
| EBIT Margin: |
80.54% |
| Net Profit Margin: |
54.24% |
| Return on Equity: |
86.54% |
| Return on Assets: |
65.02% |
Financial Strength
| Liquidity I / Cash Ratio: |
48.62% |
| Liquidity II / Quick Ratio: |
48.62% |
| Liquidity III / Current Ratio: |
432.91% |
| Debt / Equity Ratio: |
33.10% |
| Dynam. Debt / Equity Ratio: |
442.52% |
Efficiency
| Employees: |
3,082 |
| Personal Expenses / Employee: |
122,907.20 EUR |
| Revenues / Employee: |
6,157,268.01 EUR |
| Net Income / Employee: |
3,339,552.24 EUR |
| Total Assets / Employee: |
5,136,534.72 EUR |
| * Fiscal Year End: |
12/31/2021 |
